Asia · Regional markets · Vietnam Investment Review

Chinese medicine manufacturer initiates clinical heart trial in Singapore

Published by Vietnam Investment Review · Vietnam 11 h ago

Traditional Chinese medicine producer Tong Ren Tang announced clinical trials for its flagship cardiovascular formulation during a global medical conference hosted in Singapore.

Read the full article on Vietnam Investment Review Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (vir.com.vn)

Also worth reading

The Business Times

Suntec Reit Q3 DPU rises 13.4% on stronger Singapore portfolio performance

The Straits Times Business

AI-related demand powers prices, rents of Singapore industrial space in third quarter of 2026

CNBC-TV18

Q2 Results LIVE Updates: Sagility net profit up 13%; CIE Automotive India profit up 14%

Mint

163% return in 3 years! This AMC declares ₹9.50 dividend despite 6% profit dip- Do you own? Check record date

Tech in Asia

Indian AI startup ShopOS launches Sloosh content creation tool

Business Standard